Systemic Chemotherapy
Systemic Chemotherapy is a medical procedure with 30 clinical trials. Currently 2 active trials ongoing. Historical success rate of 58.8%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
10
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
47.6%
10 of 21 finished
52.4%
11 ended early
2
trials recruiting
30
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Clinical Trials (30)
Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Second Look Laparoscopy in Colorectal Cancer
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis
Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis
Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal Cancer
HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer
Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer
A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 30